IMMUNOSUPPRESSIVE drugs furnished after date of enactment of Affordable Health Care for America Act ; Regard to
Index of Sec 1232. ...PAYMENT of portion of premium under section 1839 not covered under Medicare savings program ; Individual to be responsible for providing for
Index of Sec 1232. ...SAVINGS program ; Individual to be responsible for providing for payment of portion of premium under section 1839 not covered under Medicare
Index of Sec 1232. ...1st Session |
To provide affordable, quality health care for all Americans and reduce the growth in health care spending, and for other purposes.
Mr. Dingell (for himself, Mr. Rangel, Mr. Waxman, Mr. George Miller of California, Mr. Stark, Mr. Pallone, and Mr. Andrews) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Education and Labor, Oversight and Government Reform, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
(a) Provision of appropriate coverage of immunosuppressive drugs under the medicare program for kidney transplant recipients.—
(1) CONTINUED ENTITLEMENT TO IMMUNOSUPPRESSIVE DRUGS.—
(A) KIDNEY TRANSPLANT RECIPIENTS.—Section 226A(b)(2) of the Social Security Act (42 U.S.C. 426–1(b)(2)) is amended by inserting “(except for coverage of immunosuppressive drugs under section 1861(s)(2)(J))” before “, with the thirty-sixth month”.
(B) APPLICATION.—Section 1836 of such Act (42 U.S.C. 1395o) is amended—
(i) by striking “Every individual who” and inserting “(a) In General.—Every individual who”; and
(ii) by adding at the end the following new subsection:
“(b) Special Rules Applicable to Individuals Only Eligible for Coverage of Immunosuppressive Drugs.—
“(1) IN GENERAL.—In the case of an individual whose eligibility for benefits under this title has ended on or after January 1, 2012, except for the coverage of immunosuppressive drugs by reason of section 226A(b)(2), the following rules shall apply:
“(A) The individual shall be deemed to be enrolled under this part for purposes of receiving coverage of such drugs.
“(B) The individual shall be responsible for providing for payment of the portion of the premium under section 1839 which is not covered under the Medicare savings program (as defined in section 1144(c)(7)) in order to receive such coverage.
“(C) The provision of such drugs shall be subject to the application of—
“(i) the deductible under section 1833(b); and
“(ii) the coinsurance amount applicable for such drugs (as determined under this part).
“(D) If the individual is an inpatient of a hospital or other entity, the individual is entitled to receive coverage of such drugs under this part.
“(2) ESTABLISHMENT OF PROCEDURES IN ORDER TO IMPLEMENT COVERAGE.—The Secretary shall establish procedures for—
“(A) identifying individuals that are entitled to coverage of immunosuppressive drugs by reason of section 226A(b)(2); and
“(B) distinguishing such individuals from individuals that are enrolled under this part for the complete package of benefits under this part.”.
(C) TECHNICAL AMENDMENT TO CORRECT DUPLICATE SUBSECTION DESIGNATION.—Subsection (c) of section 226A of such Act (42 U.S.C. 426–1), as added by section 201(a)(3)(D)(ii) of the Social Security Independence and Program Improvements Act of 1994 (Public Law 103–296; 108 Stat. 1497), is redesignated as subsection (d).
(2) EXTENSION OF SECONDARY PAYER REQUIREMENTS FOR ESRD BENEFICIARIES.—Section 1862(b)(1)(C) of such Act (42 U.S.C. 1395y(b)(1)(C)) is amended by adding at the end the following new sentence: “With regard to immunosuppressive drugs furnished on or after the date of the enactment of the Affordable Health Care for America Act, this subparagraph shall be applied without regard to any time limitation.”.
(b) Medicare coverage for ESRD patients.—Section 1881 of such Act is further amended—
(1) in subsection (b)(14)(B)(iii), by inserting “, including oral drugs that are not the oral equivalent of an intravenous drug (such as oral phosphate binders and calcimimetics),” after “other drugs and biologicals”;
(2) in subsection (b)(14)(E)(ii)—
(i) by striking “a one-time election to be excluded from the phase-in” and inserting “an election, with respect to 2011, 2012, or 2013, to be excluded from the phase-in (or the remainder of the phase-in)”; and
(ii) by adding before the period at the end the following: “for such year and for each subsequent year during the phase-in described in clause (i)”; and
(i) by striking “January 1, 2011” and inserting “the first date of such year”; and
(ii) by inserting “and at a time” after “form and manner”; and
(3) in subsection (h)(4)(E), by striking “lesser” and inserting “greater”.